Caplin Point Laboratories share news, announcements and annual reports
NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹2,362.80.
29 Oct: open ₹2,356.20, high ₹2,409.90, low ₹2,344.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18,061 Cr453rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.04
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 85,55750.9% delivered
Caplin Point Laboratories share news and announcements
492 announcements, routine notices left out, newest first. Page 7 of 10.
Mar 2020
26 Mar · Analysts
Feb 2020
28 Feb · Corporate action
28 Feb · Board meeting
5 Feb · Results
Jan 2020
27 Jan · Board meeting
Dec 2019
23 Dec · Updates
Nov 2019
29 Nov · Related Party Transactions
21 Nov · Updates
Oct 2019
30 Oct · Management
30 Oct · Results
25 Oct · Updates
21 Oct · Board meeting
Sep 2019
17 Sep · Amendment to AOA/MOA
13 Sep · Meeting
Aug 2019
12 Aug · Results
2 Aug · Board meeting
Jul 2019
Jun 2019
May 2019
31 May · Disclosure
22 May · Results
Apr 2019
Mar 2019
22 Mar · Business
Feb 2019
13 Feb · Disclosure
11 Feb · Results
Jan 2019
31 Jan · Analysts
24 Jan · Board meeting
18 Jan · Updates
18 Jan · Board meeting
11 Jan · Board meeting
2 Jan · Board meeting
Dec 2018
17 Dec · Updates
6 Dec · Updates